Curcumin as Add-On to Antipsychotic Treatment in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study

Conclusions The promising results of curcumin as an add-on to antipsychotics in the treatment of negative symptoms may open a new and safe therapeutic option for the management of schizophrenia. However, these results should be replicated in further studies. ClinicalTrials.gov Identifier: NCT 02298985
Source: Clinical Neuropharmacology - Category: Neurology Tags: Original Articles Source Type: research